EYA2 and familial pancreatic carcinoma: We then used methylation-specific PCR (MSP) to assess EYA2 promoter methylation in 53 pancreatic cancers (9 cell lines, 23 primary pancreatic cancer tissues and 21 xenografts of primary pancreatic cancers) and 58 normal pancreatic tissues.